Towards Healthcare Research & Consulting
Pharmacovigilance Market
Updated Date: 03 August 2026   |   Report Code: 6504

Pharmacovigilance Market Growth, Innovations, and Market Size Forecast 2035

According to Payal Rabde, who specializes in adverse events, adverse drug reactions, individual case safety reports, and drug safety surveillance, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the pharmacovigilance market. The global pharmacovigilance market size was estimated at USD 9.03 billion in 2025 and is predicted to increase from USD 9.61 billion in 2026 to approximately USD 16.87 billion by 2035, expanding at a CAGR of 6.45% from 2026 to 2035.

Last Updated : 03 August 2026 Category: Pharmaceuticals Insight Code: 6504 Format: PDF / PPT / Excel

Content

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

  • Market Dynamics
  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 7: Segmental & Regional Analysis

  • Global Pharmacovigilance Market Analysis, By Service Type
    • Market Size, Forecast & CAGR, By Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Pharmacovigilance Market Analysis, By Type
    • Market Size, Forecast & CAGR, By Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Pharmacovigilance Market Analysis, By Process Flow
    • Market Size, Forecast & CAGR, By Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Pharmacovigilance Market Analysis, By End User
    • Market Size, Forecast & CAGR, By Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Pharmacovigilance Market Analysis, By Region
    • Market Size, Forecast & CAGR, By Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Pharmacovigilance Market Analysis
  • North America Pharmacovigilance Market Analysis, By Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Pharmacovigilance Market Analysis, By Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Pharmacovigilance Market Analysis, By Process Flow, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Pharmacovigilance Market Analysis, By End User, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Pharmacovigilance Market Analysis, By Country, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
      • U. S. Pharmacovigilance Market Analysis
    • U. S. Pharmacovigilance Market Analysis, By Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U. S. Pharmacovigilance Market Analysis, By Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U. S. Pharmacovigilance Market Analysis, By Process Flow, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U. S. Pharmacovigilance Market Analysis, By End User, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Similar Analysis will be given for each country and each region

  • Canada
  • Mexico
  • Rest of North America

Europe

  • Western Europe
  • Germany
  • Italy
  • France
  • Spain
  • UK
  • Netherlands
  • Switzerland
  • Nordic Countries
  • Rest of Western Europe
  • Eastern Europe
  • Austria
  • Russia & Belarus
  • Poland
  • Türkiye
  • Rest of Eastern Europe

Asia Pacific

  • China
  • Taiwan
  • India
  • Japan
  • Vietnam
  • Australia and New Zealand
  • ASEAN Countries
  • South Korea
  • Rest of APAC

South America

  • Brazil
  • Argentina
  • Rest of South America

Middle East and Africa (MEA)

  • GCC Countries
  • South Africa
  • Egypt
  • Rest of MEA

Chapter 6: Competitive Insights

  • Competitive Analysis
    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Segment 1
      • By Segment 2
      • By Segment 3
    • Strategies of Key Players
    • Insight From the Horse’s Mouth
  • Company Profiles
    • IQVIA Holdings Inc.
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis
    • Parexel International Corporation
    • Accenture PLC
    • ICON plc
    • Cognizant Technology Solutions
    • ArisGlobal LLC
    • LabCorp / Covance
    • Thermo Fisher Scientific (PPD division)
    • Genpact Limited
    • Capgemini Services SAS

FAQ's

Answer : The pharmacovigilance market is projected to reach USD 16.87 billion by 2035, growing at a CAGR of 6.45% from 2026 to 2035.

Answer : The North America Region is currently leading the pharmacovigilance market by 42.5% due to a stringent regulatory framework, advanced healthcare infrastructure, high adoption of AI-driven safety systems, and strong pharmaceutical industry investments in drug safety monitoring.

Answer : Some key players include IQVIA, Labcorp (Covance), Syneos Health, Parexel, ICON plc, and ArisGlobal, among others.

Meet the Team

Payal Rabde is a Healthcare Market Research Analyst at Towards Healthcare Research & Consulting with 4+ years of experience in pharmaceuticals, biotechnology, medical devices, and life sciences.

Learn more about Payal Rabde

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar